News and Q&A About the New COVID Variant: OMICRON

As most Americans were wrapping up their Thanksgiving and Black Friday rituals just a few weeks ago, many felt the corner had finally been turned on COVID and we would all be able to start finally getting back to normal… instead, within days, we were all greeted with news about a new mutation of the COVID-19 virus that had been detected by scientists in Johannesburg. With so many concerns lingering as we now go into the holiday season with yet another potentially dangerous variant, Dom and John devote episode #52 of “the Weekly Bioanalysis” to reviewing the brief history of Omicron, the facts we know about Omicron so far, and the rest of the episode is devoted to “feedback from fans” as they answer a number of Omicron-related questions."The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Twice every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they've learned about the Bioanalytical world the past couple of weeks. The Weekly Bioanalysis is brought to you by KCAS.KCAS is a progressive growing contract research organization of well over 150 talented and dedicated individuals committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.